R

Rambam Health Care Campus | Internal Medicine - Cardiology Department

Research site

(Unclaimed)

Location

HALIYA HASHNIYA 8, Haifa, H̱efa, Israel

Site insights

Top conditions

Top treatments

MK-7240

MK-7240-001

Tulisokibart

Bevacizumab

ABBV-400

Parent organization

This site is a part of Rambam Health Care Campus

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active ulcerative col...

Enrolling

Ulcerative Colitis

Drug: IV Placebo

Drug: SC Placebo

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events...

Enrolling

Gastroesophageal Adenocarcinoma

Advanced Solid Tumors

Drug: ABBV-400

Drug: Trifluridine/Tipiracil

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms